AC
PFE icon

Argentiere Capital’s Pfizer PFE Stock Holding History

Argentiere Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-68,510
Closed -$2.11M – 88
2016
Q4 		$2.11M Buy
68,510
+46,092
+206% +$1.41M 0.99% 27
2016
Q3 		$720K Sell
22,418
-14,472
-39% -$484K 0.68% 27
2016
Q2 		$1.23M Sell
36,890
-286,635
-89% -$9.15M 0.96% 17
2016
Q1 		$9.1M Buy
323,525
+286,635
+777% +$8.19M 5.31% 6
2015
Q4 		$1.13M Sell
36,890
-31,620
-46% -$995K 0.52% 21
2015
Q3 		$2.04M Hold
68,510
– – 0.7% 13
2015
Q2 		$2.18M Buy
68,510
+5,270
+8% +$172K 1.44% 11
2015
Q1 		$2.09M Buy
+63,240
New +$2.01M 0.86% 21

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Argentiere Capital's PFE Position: Q1 2017 in Review

Argentiere Capital sold out of Pfizer (PFE) in Q1 2017, closing a stake of 68,510 shares — an estimated $2.11M sold.

Argentiere Capital first reported a position in PFE in Q1 2015 and held it in 8 quarters. The position peaked at $9.1M in Q1 2016. 2,075 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • Argentiere Capital reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
  • Argentiere Capital sold 68,510 Pfizer shares in Q1 2017, an estimated $2.11M.
  • Argentiere Capital first reported a position in Pfizer in Q1 2015 and held it in 8 quarters.
  • Argentiere Capital's Pfizer position peaked at $9.1M in Q1 2016.
  • 2,075 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Argentiere Capital's 13F filing for Q1 2017, filed 15 May 2017.